BEGIN:VCALENDAR
PRODID:-//Pixl8//Eventfolio//EN
VERSION:2.0
X-WR-TIMEZONE:Australia/Sydney
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:Australia/Sydney
LAST-MODIFIED:20260306T231828Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/Australia/Sydney
X-LIC-LOCATION:Australia/Sydney
BEGIN:STANDARD
TZNAME:AEST
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
DTSTART:19700405T030000
RRULE:FREQ=YEARLY;BYMONTH=4;BYDAY=1SU
END:STANDARD
BEGIN:DAYLIGHT
TZNAME:AEDT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
DTSTART:19701004T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=1SU
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20250204T190000
DTEND;TZID=Australia/Sydney:20250204T200000
DTSTAMP:20260408T230656Z
UID:{CD850A44-2B7E-4D5F-AFEF46762077FD1F}
LOCATION:
SUMMARY:Management considerations for advanced endometrial cancer patients 
DESCRIPTION:We are excited to present a webinar in collaboration with our national partner, Eisai, focused on the latest treatment strategies for advanced endometrial cancer treated with Lenvima in combination pembrolizumab and discuss what we have learnt so far.\n
 \n
 Event details: https://www.cnsa.org.au/ems-event-calendar/management-considerations-for-advanced-endometrial-cancer-patients.html
PRIORITY:1
END:VEVENT
END:VCALENDAR